130 related articles for article (PubMed ID: 37149961)
1. Hydrocortisone to reduce dexamethasone-induced neurobehavioral side-effects in children with acute lymphoblastic leukaemia-results of a double-blind, randomised controlled trial with cross-over design.
van Hulst AM; van den Akker ELT; Verwaaijen EJ; Fiocco M; Rensen N; van Litsenburg RRL; Pluijm SMF; Zwaan CM; van Santen HM; Pieters R; Evers AWM; Grootenhuis MA; van den Heuvel-Eibrink MM
Eur J Cancer; 2023 Jul; 187():124-133. PubMed ID: 37149961
[TBL] [Abstract][Full Text] [Related]
2. Study protocol: DexaDays-2, hydrocortisone for treatment of dexamethasone-induced neurobehavioral side effects in pediatric leukemia patients: a double-blind placebo controlled randomized intervention study with cross-over design.
van Hulst AM; Verwaaijen EJ; Fiocco MF; Pluijm SMF; Grootenhuis MA; Pieters R; van den Akker ELT; van den Heuvel-Eibrink MM
BMC Pediatr; 2021 Sep; 21(1):427. PubMed ID: 34579671
[TBL] [Abstract][Full Text] [Related]
3. Hydrocortisone as an Intervention for Dexamethasone-Induced Adverse Effects in Pediatric Patients With Acute Lymphoblastic Leukemia: Results of a Double-Blind, Randomized Controlled Trial.
Warris LT; van den Heuvel-Eibrink MM; Aarsen FK; Pluijm SM; Bierings MB; van den Bos C; Zwaan CM; Thygesen HH; Tissing WJ; Veening MA; Pieters R; van den Akker EL
J Clin Oncol; 2016 Jul; 34(19):2287-93. PubMed ID: 27161966
[TBL] [Abstract][Full Text] [Related]
4. Unraveling Dexamethasone-Induced Neurobehavioral and Sleep Problems in Children With ALL: Which Determinants Are Important?
van Hulst AM; Grootenhuis MA; Verwaaijen EJ; van Litsenburg RRL; Li L; van Zelst BD; Broer L; Pluijm SMF; Pieters R; Fiocco M; van den Akker ELT; van den Heuvel-Eibrink MM
JCO Precis Oncol; 2023 Jun; 7():e2200678. PubMed ID: 37343203
[TBL] [Abstract][Full Text] [Related]
5. Re: Hydrocortisone to reduce dexamethasone-induced neurobehavioral side-effects in children with acute lymphoblastic leukaemia-results of a double-blind, randomised controlled trial with cross-over design.
Zhang D; Gu M
Eur J Cancer; 2023 Sep; 191():112979. PubMed ID: 37532597
[No Abstract] [Full Text] [Related]
6. Predicting the neurobehavioral side effects of dexamethasone in pediatric acute lymphoblastic leukemia.
Warris LT; van den Akker EL; Aarsen FK; Bierings MB; van den Bos C; Tissing WJ; Sassen SD; Veening MA; Zwaan CM; Pieters R; van den Heuvel-Eibrink MM
Psychoneuroendocrinology; 2016 Oct; 72():190-5. PubMed ID: 27448086
[TBL] [Abstract][Full Text] [Related]
7. Response to letter entitled: Re: Hydrocortisone to reduce dexamethasone-induced neurobehavioral side-effects in children with acute lymphoblastic leukaemia-results of a double-blind, randomised controlled trial with cross-over design.
van Hulst AM; Grootenhuis MA; van den Akker ELT; van den Heuvel-Eibrink MM
Eur J Cancer; 2023 Sep; 191():112980. PubMed ID: 37574396
[No Abstract] [Full Text] [Related]
8. Pulse therapy with vincristine and dexamethasone for childhood acute lymphoblastic leukaemia (CCCG-ALL-2015): an open-label, multicentre, randomised, phase 3, non-inferiority trial.
Yang W; Cai J; Shen S; Gao J; Yu J; Hu S; Jiang H; Fang Y; Liang C; Ju X; Wu X; Zhai X; Tian X; Wang N; Liu A; Jiang H; Jin R; Sun L; Yang M; Leung AWK; Pan K; Zhang Y; Chen J; Zhu Y; Zhang H; Li C; Yang JJ; Cheng C; Li CK; Tang J; Zhu X; Pui CH
Lancet Oncol; 2021 Sep; 22(9):1322-1332. PubMed ID: 34329606
[TBL] [Abstract][Full Text] [Related]
9. The use of MElatonin in children with neurodevelopmental disorders and impaired sleep: a randomised, double-blind, placebo-controlled, parallel study (MENDS).
Appleton RE; Jones AP; Gamble C; Williamson PR; Wiggs L; Montgomery P; Sutcliffe A; Barker C; Gringras P
Health Technol Assess; 2012; 16(40):i-239. PubMed ID: 23098680
[TBL] [Abstract][Full Text] [Related]
10. Leukoencephalopathy and long-term neurobehavioural, neurocognitive, and brain imaging outcomes in survivors of childhood acute lymphoblastic leukaemia treated with chemotherapy: a longitudinal analysis.
Cheung YT; Sabin ND; Reddick WE; Bhojwani D; Liu W; Brinkman TM; Glass JO; Hwang SN; Srivastava D; Pui CH; Robison LL; Hudson MM; Krull KR
Lancet Haematol; 2016 Oct; 3(10):e456-e466. PubMed ID: 27658980
[TBL] [Abstract][Full Text] [Related]
11. The impact of maintenance therapy on sleep-wake rhythms and cancer-related fatigue in pediatric acute lymphoblastic leukemia.
Steur LMH; Kaspers GJL; van Someren EJW; van Eijkelenburg NKA; van der Sluis IM; Dors N; van den Bos C; Tissing WJE; Grootenhuis MA; van Litsenburg RRL
Support Care Cancer; 2020 Dec; 28(12):5983-5993. PubMed ID: 32285260
[TBL] [Abstract][Full Text] [Related]
12. The DEXA-CORT trial: study protocol of a randomised placebo-controlled trial of hydrocortisone in patients with brain tumour on the prevention of neuropsychiatric adverse effects caused by perioperative dexamethasone.
Koning ACAM; Satoer DD; Vinkers CH; Zamanipoor Najafabadi AH; Biermasz NR; Nandoe Tewarie RDS; Moojen WA; van Rossum EFC; Dirven CMF; Pereira AM; van Furth WR; Meijer OC
BMJ Open; 2021 Dec; 11(12):e054405. PubMed ID: 37057711
[TBL] [Abstract][Full Text] [Related]
13. Leptin Increase During Dexamethasone and Its Association With Hunger and Fat in Pediatric Acute Lymphoblastic Leukemia.
van Hulst AM; Verwaaijen EJ; van den Berg SAA; van Litsenburg RRL; Grootenhuis MA; Fiocco M; Neggers SJCMM; van den Heuvel-Eibrink MM; van den Akker ELT
J Clin Endocrinol Metab; 2024 Feb; 109(3):631-640. PubMed ID: 37878899
[TBL] [Abstract][Full Text] [Related]
14. Parental functioning during maintenance treatment for childhood acute lymphoblastic leukemia: Effects of treatment intensity and dexamethasone pulses.
Rensen N; Steur LMH; Grootenhuis MA; van Eijkelenburg NKA; van der Sluis IM; Dors N; van den Bos C; Tissing WJE; Kaspers GJL; van Litsenburg RRL
Pediatr Blood Cancer; 2020 Nov; 67(11):e28697. PubMed ID: 32909677
[TBL] [Abstract][Full Text] [Related]
15. The effects of dexamethasone on sleep in young children with acute lymphoblastic leukemia.
Rosen G; Harris AK; Liu M; Dreyfus J; Krueger J; Messinger YH
Sleep Med; 2015 Apr; 16(4):503-9. PubMed ID: 25799940
[TBL] [Abstract][Full Text] [Related]
16. Hypothalamic-pituitary-adrenal (HPA) axis suppression after treatment with glucocorticoid therapy for childhood acute lymphoblastic leukaemia.
Rensen N; Gemke RJ; van Dalen EC; Rotteveel J; Kaspers GJ
Cochrane Database Syst Rev; 2017 Nov; 11(11):CD008727. PubMed ID: 29106702
[TBL] [Abstract][Full Text] [Related]
17. Lansoprazole for persistent throat symptoms in secondary care: the TOPPITS RCT.
Wilson JA; Stocken DD; Watson GC; Fouweather T; McGlashan J; MacKenzie K; Carding P; Karagama Y; Harries M; Ball S; Khwaja S; Costello D; Wood R; Lecouturier J; O'Hara J
Health Technol Assess; 2021 Jan; 25(3):1-118. PubMed ID: 33492208
[TBL] [Abstract][Full Text] [Related]
18. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
19. Impaired sleep affects quality of life in children during maintenance treatment for acute lymphoblastic leukemia: an exploratory study.
van Litsenburg RR; Huisman J; Hoogerbrugge PM; Egeler RM; Kaspers GJ; Gemke RJ
Health Qual Life Outcomes; 2011 Apr; 9():25. PubMed ID: 21496357
[TBL] [Abstract][Full Text] [Related]
20. Dexamethasone-based therapy for childhood acute lymphoblastic leukaemia: results of the prospective Dutch Childhood Oncology Group (DCOG) protocol ALL-9 (1997-2004).
Veerman AJ; Kamps WA; van den Berg H; van den Berg E; Bökkerink JP; Bruin MC; van den Heuvel-Eibrink MM; Korbijn CM; Korthof ET; van der Pal K; Stijnen T; van Weel Sipman MH; van Weerden JF; van Wering ER; van der Does-van den Berg A;
Lancet Oncol; 2009 Oct; 10(10):957-66. PubMed ID: 19747876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
